Envestnet Asset Management Inc. Acquires Shares of 223,866 SPDR S&P Pharmaceuticals ETF $XPH

Envestnet Asset Management Inc. acquired a new position in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 223,866 shares of the company’s stock, valued at approximately $10,732,000. Envestnet Asset Management Inc. owned 0.06% of SPDR S&P Pharmaceuticals ETF as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently modified their holdings of the company. First Citizens Bank & Trust Co. increased its stake in shares of SPDR S&P Pharmaceuticals ETF by 2.9% in the 3rd quarter. First Citizens Bank & Trust Co. now owns 181,429 shares of the company’s stock valued at $8,698,000 after purchasing an additional 5,038 shares in the last quarter. Envestnet Portfolio Solutions Inc. grew its holdings in SPDR S&P Pharmaceuticals ETF by 6.7% in the third quarter. Envestnet Portfolio Solutions Inc. now owns 171,930 shares of the company’s stock valued at $8,242,000 after purchasing an additional 10,842 shares during the period. Park Avenue Securities LLC purchased a new stake in shares of SPDR S&P Pharmaceuticals ETF in the third quarter valued at approximately $485,000. U.S. Capital Wealth Advisors LLC raised its stake in shares of SPDR S&P Pharmaceuticals ETF by 2.6% during the 3rd quarter. U.S. Capital Wealth Advisors LLC now owns 14,730 shares of the company’s stock worth $706,000 after buying an additional 378 shares during the period. Finally, Corient Private Wealth LLC purchased a new position in shares of SPDR S&P Pharmaceuticals ETF during the 2nd quarter valued at approximately $294,000.

SPDR S&P Pharmaceuticals ETF Stock Performance

SPDR S&P Pharmaceuticals ETF stock opened at $57.40 on Thursday. The stock has a market capitalization of $298.48 million, a P/E ratio of 14.28 and a beta of 0.60. The company’s fifty day moving average price is $56.42 and its 200 day moving average price is $51.36. SPDR S&P Pharmaceuticals ETF has a 1 year low of $35.22 and a 1 year high of $58.14.

About SPDR S&P Pharmaceuticals ETF

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.